Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
Hepatology (Baltimore, Md.)|June 19, 2012
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trialsPatrick Marcellin, Hugo Cheinquer, Manuela Curescu, et al.
Journal of Hepatology|August 4, 2004
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patientsMassimo Puoti, Barbara Zanini, Gian Paolo Quinzan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2010
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patientsGiovanna Fattovich, Loredana Covolo, Michela Pasino, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2023
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohortRoberta D'Ambrosio, Sara Piccinelli, Benedetta Beccalli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2026
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST StudyRoberto Rossotti, Chiara Baiguera, Davide Paolo Bernasconi, et al.
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus InfectionBarbara Rossetti, Valentina Borgo, Arianna Emiliozzi, et al.
Lancet (London, England)|February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 studyJean-Michel Molina, Chloe Orkin, David M Iser, et al.
BMC Infectious Diseases|July 16, 2005
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER CohortCarlo Torti, Giuseppe Lapadula, Salvatore Casari, et al.
Viruses|June 2, 2021
Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?Valeria Cento, Silvia Renica, Elisa Matarazzo, et al.
Pageof 24